Host Genetic Control of HIV

HIV的宿主基因控制

• 批准号: 8727500
• 负责人: Richard Sutton
• 金额: $ 74.61万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-15 至 2018-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8727500
• 关键词: Alcohol or Other Drugs use; Amino Acids; Antiviral Agents; Binding; CD4 Positive T Lymphocytes; Candidate Disease Gene; Cell Count; Cells; Chinese People; Collaborations; DNA; Family Study; Gene Mutation; Genes; Genetic; Genomic DNA; HIV; HIV Infections; HLA-B Antigens; Health; Immunologic Deficiency Syndromes; In Vitro; Individual; Inheritance Patterns; Modeling; Mutation; Patients; Peptides; Peripheral; Pharmaceutical Preparations; Phenotype; Research Personnel; Resistance; Risk Factors; T-Cell Depletion; Testing; Vaccines; Veterans; Viral; Virus; cohort; exome sequencing; genome wide association study; man; patient population

DESCRIPTION (provided by applicant): For most infected individuals, HIV leads inexorably to CD4+ T cell depletion and profound immunodeficiency. For a fortunate few HIV infection results in extremely limited viral replication and peripheral CD4+ T cell counts are maintained. These patients, termed 'Elite Controllers', have been subject to intensive study since understanding how they control the virus should inform the vaccine effort. A large GWAS of ECs identified several non-synonymous amino acid changes in the peptide binding pocket of HLA-B that are associated with the EC phenotype. Those mutations, however, were only responsible for ~20% of the observed effect, and it has been suggested that much rarer, 'private' mutations that would not be uncovered by even a larger GWAS are responsible for the majority of the EC phenotype. I wish to identify those rare genetic mutations that may be contributing to the exquisite control o HIV in ECs. To do so, I propose whole exome sequencing (WES) of genomic DNA from ECs. Our group has completed WES of ~24 ECs and already has several promising gene leads; we now wish to expand exome sequencing to dozens of other ECs throughout the U.S. and world. Patient populations include Ethiopians (in collaboration with investigators in Addis Ababa and Makele), Spaniards (from a large cohort of ECs that are substance users), Chinese, and U.S. Veterans (many of whom have substance use as their HIV acquisition risk factor). Candidate genes identified from WES will be subjected to in vitro functional studies. Importantly, we have identified a subset of ECs who have cell-intrinsic resistance to HIV. Those ECs will allow us to explore the genetics of elite control, with a focus on family studies, in order to determine inheritance patterns and causative genes. In the end I hope to have identified genetic factors responsible for host control of HIV.

描述(由申请人提供)：对于大多数感染者，艾滋病毒无情地导致CD4+T细胞耗尽和严重的免疫缺陷。对于少数幸运儿来说，艾滋病毒感染导致病毒复制极其有限，外周CD4+T细胞计数保持不变。这些被称为“精英控制者”的患者一直受到深入研究，因为了解他们是如何控制病毒的应该为疫苗工作提供信息。一大批内皮细胞在人类白细胞抗原-B的多肽结合口袋中发现了几个与EC表型相关的非同义氨基酸变化。然而，这些突变只占观察到的效应的~20%，而且有人认为，更罕见的“私人”突变是大多数EC表型的原因，即使是更大的GWAS也不会发现这些突变。我希望找出那些罕见的基因突变，这些突变可能有助于在ECs中精细地控制艾滋病毒。为了做到这一点，我建议对ECs的基因组DNA进行完整的外显子组测序。我们小组已经完成了~24个EC的WES，并且已经有了几个有希望的基因线索；我们现在希望将外显子组测序扩展到美国和世界各地的数十个其他EC。患者群体包括埃塞俄比亚人(与亚的斯亚贝巴和马克勒的调查人员合作)、西班牙人(来自大量吸毒者)、中国人和美国退伍军人(其中许多人将吸食药物作为其艾滋病毒感染的风险因素)。从WES中确定的候选基因将接受体外功能研究。重要的是，我们已经确定了对艾滋病毒具有细胞固有抵抗力的一部分内皮细胞。这些ECs将使我们能够探索精英控制的遗传学，重点放在家族研究上，以确定遗传模式和致病基因。最后，我希望能找出宿主控制艾滋病毒的遗传因素。